Literature DB >> 24283757

Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.

Gamze Kilic1, Erkan Kilic1, Ozgur Akgul1, Salih Ozgocmen1.   

Abstract

AIM: To assess bone mass in women with systemic sclerosis (SSc) in comparison to age and sex-matched patients with rheumatoid arthritis (RA), and to evaluate factors influencing bone mineral density (BMD).
METHODS: Patients were consecutively recruited and assessed for BMD at the lumbar spine and hip by dual-energy X-ray absorptiometry (DEXA) using a densitometer. In SSc, the extent of skin involvement, modified Rodnan skin thickness score (mRSS) and Medsger disease severity index were assessed.
RESULTS: Forty-three patients with SSc and 38 age-matched patients with RA were included. There was no difference in BMD measurements between patients with diffuse or limited SSc. Patients with SSc had similar risk factors associated with osteoporosis (OP) or low bone mass except for low body mass index (BMI) and low vitamin D levels compared to patients with RA. Lumbar spinal BMD and T score were similar between groups. Total hip and femoral neck BMD and T score at femoral neck and total hip were significantly lower in patient with SSc versus RA. There was significant association between mRSS, Medsger severity score (peripheral vascular involvement and skin) and femoral BMD.
CONCLUSION: There is an increased risk for bone loss in patients with SSc and the risk of OP is associated with disease severity, prolonged menopause and disease duration. The complex pathophysiology of bone metabolism as well as complex pathogenesis of the SSc pose some difficulty reaching clear-cut conclusions on the causal relationship between SSc and bone loss.
© 2013 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  bone density; disease severity; rheumatoid arthritis; skin; systemic sclerosis

Mesh:

Substances:

Year:  2013        PMID: 24283757     DOI: 10.1111/1756-185X.12242

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  8 in total

1.  Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.

Authors:  Chider Chen; Dandan Wang; Alireza Moshaverinia; Dawei Liu; Xiaoxing Kou; Wenjing Yu; Ruili Yang; Lingyun Sun; Songtao Shi
Journal:  Cell Res       Date:  2017-01-20       Impact factor: 25.617

2.  Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.

Authors:  Marine Fauny; Elodie Bauer; Eliane Albuisson; Julia Perrier-Cornet; Joëlle Deibener; François Chabot; Damien Mandry; Olivier Huttin; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  Rheumatol Int       Date:  2018-08-21       Impact factor: 2.631

3.  Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis.

Authors:  M M Sampaio-Barros; J C Alvarenga; L Takayama; A P L Assad; P D Sampaio-Barros; R M R Pereira
Journal:  Osteoporos Int       Date:  2019-04-27       Impact factor: 4.507

Review 4.  Comorbidity burden in systemic sclerosis: beyond disease-specific complications.

Authors:  Eleni Pagkopoulou; Alexandra Arvanitaki; Dimitrios Daoussis; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2019-07-12       Impact factor: 2.631

5.  Relationship between ectopic calcifications and bone fragility depicted on computed tomography scan in 70 patients with systemic sclerosis.

Authors:  Marine Fauny; Elodie Bauer; Edem Allado; Eliane Albuisson; Joëlle Deibener; François Chabot; Damien Mandry; Olivier Huttin; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  J Scleroderma Relat Disord       Date:  2022-06-28

6.  A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis.

Authors:  Juan Chen; Ling Lei; Jie Pan; Cheng Zhao
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

7.  mTOR inhibition rescues osteopenia in mice with systemic sclerosis.

Authors:  Chider Chen; Kentaro Akiyama; Dandan Wang; Xingtian Xu; Bei Li; Alireza Moshaverinia; Frank Brombacher; Lingyun Sun; Songtao Shi
Journal:  J Exp Med       Date:  2014-12-22       Impact factor: 14.307

8.  Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases.

Authors:  Zhuoran Hu; Shuiming Xu; He Lin; Weifeng Ni; Qingyuan Yang; Jun Qi; Keqian Du; Jieruo Gu; Zhiming Lin
Journal:  BMC Musculoskelet Disord       Date:  2020-06-30       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.